BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tejeda-Maldonado J, García-Juárez I, Aguirre-Valadez J, González-Aguirre A, Vilatobá-Chapa M, Armengol-Alonso A, Escobar-Penagos F, Torre A, Sánchez-Ávila JF, Carrillo-Pérez DL. Diagnosis and treatment of hepatocellular carcinoma: An update. World J Hepatol 2015; 7(3): 362-376 [PMID: 25848464 DOI: 10.4254/wjh.v7.i3.362]
URL: https://www.wjgnet.com/1948-5182/full/v7/i3/362.htm
Number Citing Articles
1
Jingyue Yang, Bo Qiu, Xiao Li, Hongmei Zhang, Wenchao Liu. p53-p66shc/miR-21-Sod2 signaling is critical for the inhibitory effect of betulinic acid on hepatocellular carcinomaToxicology Letters 2015; 238(3): 1 doi: 10.1016/j.toxlet.2015.07.016
2
Elisa Salvati, Francesco Stellacci, Silke Krol. Nanosensors for early cancer detection and for therapeutic drug monitoringNanomedicine 2015; 10(23): 3495 doi: 10.2217/nnm.15.180
3
Xin Li, Jie Yu, Ping Liang, Xiaoling Yu, Zhigang Cheng, Zhiyu Han, Shaobo Duan, Jiasheng Zheng. Ultrasound-guided percutaneous microwave ablation assisted by three-dimensional visualization operative treatment planning system and percutaneous transhepatic cholangial drainage with intraductal chilled saline perfusion for larger hepatic hilum hepatocellular (D ≥ 3 cm): preliminary resultsOncotarget 2017; 8(45): 79742 doi: 10.18632/oncotarget.19275
4
Ioannis A Ziogas, Georgios Tsoulfas. Advances and challenges in laparoscopic surgery in the management of hepatocellular carcinomaWorld Journal of Gastrointestinal Surgery 2017; 9(12): 233-245 doi: 10.4240/wjgs.v9.i12.233
5
Xiao-Xiao Ding, Qing-Ge Zhu, Shi-Ming Zhang, Lei Guan, Ting Li, Lei Zhang, Shi-Yang Wang, Wan-Li Ren, Xue-Mei Chen, Jing Zhao, Song Lin, Zhi-Zhen Liu, Yan-Xia Bai, Bing He, Hu-Qin Zhang. Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapyOncotarget 2017; 8(33): 55715 doi: 10.18632/oncotarget.18382
6
Satoshi Kokura. Hyperthermic Oncology from Bench to Bedside2016; : 261 doi: 10.1007/978-981-10-0719-4_25
7
Eric Waidely, Abdulrahman O. Al-Youbi, Abdulaziz S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc. Study of the Alpha-l-Fucosidase Langmuir Monolayer at the Air–Water InterfaceThe Journal of Physical Chemistry B 2016; 120(50): 12843 doi: 10.1021/acs.jpcb.6b09094
8
Jing Xie, Aihua Zhang, Xijun Wang. Metabolomic applications in hepatocellular carcinoma: toward the exploration of therapeutics and diagnosis through small moleculesRSC Advances 2017; 7(28): 17217 doi: 10.1039/C7RA00698E
9
Chengxu Ruan, Lijuan You, Yingdong Qiu, Xiao Cui, Defeng Wu. Tubeimoside I induces autophagy in HepG2 cells by activating the AMP‑activated protein kinase signaling pathwayOncology Letters 2020; 20(1): 623 doi: 10.3892/ol.2020.11604
10
Jia-yan Ni, Jian Kong, Hong-liang Sun, Yao-ting Chen, Jiang-hong Luo, Wei-dong Wang, Dong Chen, Xiong-ying Jiang, Lin-feng Xu. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular CarcinomasAcademic Radiology 2018; 25(4): 423 doi: 10.1016/j.acra.2017.10.018
11
Li Zhang, Jiasheng Chen, Chunming Gao, Chuanmiao Liu, Kuihua Xu. An efficient model for auxiliary diagnosis of hepatocellular carcinoma based on gene expression programmingMedical & Biological Engineering & Computing 2018; 56(10): 1771 doi: 10.1007/s11517-018-1811-6
12
Celia Sequera, Sara Manzano, Carmen Guerrero, Almudena Porras. How Rap and its GEFs control liver physiology and cancer development. C3G alterations in human hepatocarcinomaHepatic Oncology 2018; 5(1): HEP05 doi: 10.2217/hep-2017-0026
13
Haijin Huang, Yan‐Zhi Bu, Xiao‐Yu Zhang, Juan Liu, Li‐Yao Zhu, Yong Fang. LINC01433 promotes hepatocellular carcinoma progression via modulating the miR‐1301/STAT3 axisJournal of Cellular Physiology 2019; 234(5): 6116 doi: 10.1002/jcp.27366
14
Bin Xu, Tangpeng Xu, Huali Liu, Qian Min, Shidong Wang, Qibin Song. MiR-490-5p Suppresses Cell Proliferation and Invasion by Targeting BUB1 in Hepatocellular Carcinoma CellsPharmacology 2017; 100(5-6): 269 doi: 10.1159/000477667
15
Keenan Mintz, Eric Waidely, Yiqun Zhou, Zhili Peng, Abdulrahman O. Al-Youbi, Abdulaziz S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc. Carbon dots and gold nanoparticles based immunoassay for detection of alpha-L-fucosidaseAnalytica Chimica Acta 2018; 1041: 114 doi: 10.1016/j.aca.2018.08.055
16
Jian-Jun Gao, Zhen-Yan Shi, Ju-Feng Xia, Yoshinori Inagaki, Wei Tang. Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(42): 12059-12070 doi: 10.3748/wjg.v21.i42.12059
17
Mahfoozur Rahman, Kainat Alam, Rafida Ilyas, Sarwar Beg. Nanoformulation Strategies for Cancer Treatment2021; : 171 doi: 10.1016/B978-0-12-821095-6.00015-X
18
Da-wei Sun, Ying-yi Zhang, Xiao-dong Sun, Yu-guo Chen, Wei Qiu, Min Ji, Guo-yue Lv. Prognostic value of cytokeratin 19 in hepatocellular carcinoma: A meta-analysisClinica Chimica Acta 2015; 448: 161 doi: 10.1016/j.cca.2015.06.027
19
Pavan Patel, Steven E Schutzer, Nikolaos Pyrsopoulos. Immunobiology of hepatocarcinogenesis: Ways to go or almost there?World Journal of Gastrointestinal Pathophysiology 2016; 7(3): 242-255 doi: 10.4291/wjgp.v7.i3.242
20
Chunmei Xie, Christian Tiede, Xuanyi Zhang, Congrong Wang, Zhixiong Li, Xiao Xu, Michael J. McPherson, Darren C. Tomlinson, Weiwen Xu. Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10083-w
21
Peng-Sheng Yi, Hong Wang, Jian-Shui Li. Evolution and current status of the subclassification of intermediate hepatocellular carcinomaWorld Journal of Gastrointestinal Surgery 2020; 12(3): 85-92 doi: 10.4240/wjgs.v12.i3.85
22
Zhengwei Li, Ying Wang. miR-96 targets SOX6 and promotes proliferation, migration, and invasion of hepatocellular carcinomaBiochemistry and Cell Biology 2018; 96(3): 365 doi: 10.1139/bcb-2017-0183
23
Chou-Yuan Ko, Po-Chang Shih, Po-Wei Huang, Yi-Hsin Lee, Yen-Fu Chen, Ming-Hong Tai, Chi-Hao Liu, Zhi-Hong Wen, Hsiao-Mei Kuo. Sinularin, an Anti-Cancer Agent Causing Mitochondria-Modulated Apoptosis and Cytoskeleton Disruption in Human Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2021; 22(8): 3946 doi: 10.3390/ijms22083946
24
Michelle Meier, Kasper Jarlhelt Andersen, Anders Riegels Knudsen, Jens Randel Nyengaard, Stephen Hamilton-Dutoit, Frank Viborg Mortensen. Liver regeneration is dependent on the extent of hepatectomyJournal of Surgical Research 2016; 205(1): 76 doi: 10.1016/j.jss.2016.06.020
25
Yingru Zhi, Mubalake Abudoureyimu, Hao Zhou, Ting Wang, Bing Feng, Rui Wang, Xiaoyuan Chu. FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular CarcinomaMolecular Therapy - Nucleic Acids 2019; 16: 576 doi: 10.1016/j.omtn.2019.04.008
26
Mahfoozur Rahman, Waleed H Almalki, Majed Alrobaian, Jawed Iqbal, Saad Alghamdi, Khalid S Alharbi, Nabil K Alruwaili, Abdul Hafeez, Adil Shaharyar, Tanuja Singh, Mohammad Waris, Vikas Kumar, Sarwar Beg. Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinomaExpert Opinion on Drug Delivery 2021; 18(4): 489 doi: 10.1080/17425247.2021.1854223
27
Yantian Xu, Yuanwen Zheng, Hongyan Liu, Tao Li. Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transductionInternational Journal of Oncology 2017; 51(3): 791 doi: 10.3892/ijo.2017.4066
28
Giuseppe Tarantino, Paolo Magistri, Roberto Ballarin, Raffaele Di Francia, Massimiliano Berretta, Fabrizio Di Benedetto. Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the LiteratureFrontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00387
29
Yitian Qi, Yi Hou, Liangchen Qi. miR-30d-5p represses the proliferation, migration, and invasion of lung squamous cell carcinoma via targeting DBF4Journal of Environmental Science and Health, Part C 2021; : 1 doi: 10.1080/26896583.2021.1926855
30
Mengxuan Lu, Xia Kong, Huaigao Wang, Guoliang Huang, Caiguo Ye, Zhiwei He. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosisOncotarget 2017; 8(5): 8775 doi: 10.18632/oncotarget.14452
31
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, NAOKI ISHIGE. Suppressive effects of 3-bromopyruvate on the proliferation and the motility of hepatocellular carcinoma cellsOncology Reports 2016; 35(1): 59 doi: 10.3892/or.2015.4370
32
Yukimasa Makita, Shumpei Murata, Yoshiki Katou, Kuniko Kikuchi, Hiroshi Uejima, Mika Teratani, Yasutaka Hoashi, Eriya Kenjo, Satoru Matsumoto, Masahiro Nogami, Kentaro Otake, Yuji Kawamata. Anti-tumor activity of KNTC2 siRNA in orthotopic tumor model mice of hepatocellular carcinomaBiochemical and Biophysical Research Communications 2017; 493(1): 800 doi: 10.1016/j.bbrc.2017.08.088
33
Hisashi Nakayama, Tadatoshi Takayama. Management before hepatectomy for hepatocellular carcinoma with cirrhosisWorld Journal of Hepatology 2015; 7(20): 2292-2302 doi: 10.4254/wjh.v7.i20.2292
34
Xiaoxiao Qin, Xiaojun Hu, Chun Wu, Mingyue Cai, Zhengran Li, Lina Zhang, Liteng Lin, Wensou Huang, Kangshun Zhu. Hepatocellular Carcinoma Cells Carrying a Multimodality Reporter Gene for Fluorescence, Bioluminescence, and Magnetic Resonance Imaging In Vitro and In VivoAcademic Radiology 2016; 23(11): 1422 doi: 10.1016/j.acra.2016.07.009
35
Xiangrui Meng, Peng Lu, Qingxia Fan. RETRACTED: miR-367 promotes proliferation and invasion of hepatocellular carcinoma cells by negatively regulating PTENBiochemical and Biophysical Research Communications 2016; 470(1): 187 doi: 10.1016/j.bbrc.2016.01.025
36
Eric Waidely, Abdul-Rahman Obaid Al-Yuobi, A. S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc. Serum protein biomarkers relevant to hepatocellular carcinoma and their detectionThe Analyst 2016; 141(1): 36 doi: 10.1039/C5AN01884F
37
Qi-Zhe Gong, Di Xiao, Gui-Yi Gong, Jian Xu, Xiao-Dong Wen, Feng Feng, Wei Qu. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling PathwayCurrent Cancer Drug Targets 2019; 19(7): 583 doi: 10.2174/1568009619666181226094814
38
Kika Anyiwe, Yao Qiao, Prithwish De, Eric M. Yoshida, Craig C. Earle, Hla-Hla Thein. Effect of socioeconomic status on hepatocellular carcinoma incidence and stage at diagnosis, a population-based cohort studyLiver International 2016; 36(6): 902 doi: 10.1111/liv.12982
39
Claudia Conte, Sara Maiolino, Diogo Silva Pellosi, Agnese Miro, Francesca Ungaro, Fabiana Quaglia. Light-Responsive Nanostructured Systems for Applications in NanomedicineTopics in Current Chemistry 2016; 370: 61 doi: 10.1007/978-3-319-22942-3_3
40
Meiwan Chen, Xingzhi Zhou, Ruie Chen, Junlin Wang, Richard D. Ye, Yitao Wang, Chuanbin Wu, Ram I. Mahato. Nano-carriers for delivery and targeting of active ingredients of Chinese medicine for hepatocellular carcinoma therapyMaterials Today 2019; 25: 66 doi: 10.1016/j.mattod.2018.10.040
41
Xingqing Jia, Shuangqin Wei, Wujun Xiong, Muhammad Wasim Khan. CXCL5/NF-κB Pathway as a Therapeutic Target in Hepatocellular Carcinoma TreatmentJournal of Oncology 2021; 2021: 1 doi: 10.1155/2021/9919494
42
Baoguo Li, Rui Mao, Changfu Liu, Weihao Zhang, Yong Tang, Zhi Guo. LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cellsLife Sciences 2018; 197: 122 doi: 10.1016/j.lfs.2018.02.006
43
Qian Ding, Xiang-Guo Tian, Yan Li, Qi-Zhi Wang, Chun-Qing Zhang. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathwayWorld Journal of Gastroenterology 2015; 21(32): 9566-9576 doi: 10.3748/wjg.v21.i32.9566
44
Shiping Hu, Yun Ran, Wenlin Chen, Yuncheng Zhang, Yongjian Xu. MicroRNA-326 inhibits cell proliferation and invasion, activating apoptosis in hepatocellular carcinoma by directly targeting LIM and SH3 protein 1Oncology Reports 2017; 38(3): 1569 doi: 10.3892/or.2017.5810
45
Jing Hu, Jing Zhang, Feifei Sun, Mei Qi, Peng Su, Hui Liu, Lin Gao, Meng Jiao, Zhen Wu, Lei Xiang, Bo Han. Enhancer of zeste 2 polycomb repressive complex 2 subunit promotes sorafenib resistance of hepatocellular carcinoma though insulin-like growth factor 1 receptorAnti-Cancer Drugs 2019; 30(7): 677 doi: 10.1097/CAD.0000000000000746
46
Liying Guo, Kai Tan, Hao Wang, Xuan Zhang. Pterostilbene inhibits hepatocellular carcinoma through p53/SOD2/ROS-mediated mitochondrial apoptosisOncology Reports 2016; 36(6): 3233 doi: 10.3892/or.2016.5151
47
Li Xu, Yuanrun Zhu, Jinjin Shao, Min Chen, Hao Yan, Guanqun Li, Yi Zhu, Zhifei Xu, Bo Yang, Peihua Luo, Qiaojun He. Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1British Journal of Cancer 2017; 116(8): 1027 doi: 10.1038/bjc.2017.55
48
Phuriwat Khiewkamrop, Pattamaphron Phunsomboon, Lysiane Richert, Dumrongsak Pekthong, Piyarat Srisawang. Epistructured catechins, EGCG and EC facilitate apoptosis induction through targeting de novo lipogenesis pathway in HepG2 cellsCancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0539-6
49
Kai-Po Chang, Shih-Huan Lin, Yen-Wei Chu. Artificial intelligence in gastrointestinal radiology: A review with special focus on recent development of magnetic resonance and computed tomographyArtificial Intelligence in Gastroenterology 2021; 2(2): 27-41 doi: 10.35712/aig.v2.i2.27
50
Christina Schraml, Sascha Kaufmann, Hansjoerg Rempp, Roland Syha, Dominik Ketelsen, Mike Notohamiprodjo, Konstantin Nikolaou. Imaging of HCC—Current State of the ArtDiagnostics 2015; 5(4): 513 doi: 10.3390/diagnostics5040513
51
Eric Waidely, Abdulrahman O. Al-Youbi, Abdulaziz S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc. Alpha-l-Fucosidase Immunoassay for Early Detection of Hepatocellular CarcinomaAnalytical Chemistry 2017; 89(17): 9459 doi: 10.1021/acs.analchem.7b02284
52
Yanmin Xu, Ji Huang, Leina Ma, Juanjuan Shan, Junjie Shen, Zhi Yang, Limei Liu, Yongli Luo, Chao Yao, Cheng Qian. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathwaysCancer Letters 2016; 371(2): 171 doi: 10.1016/j.canlet.2015.11.034
53
Lina Wang, Qin Ding, Li Zhao, Yu Pan, Zhengxia Song, Yanan Qin, Xuebing Yan. Decreased BMP‑7 and p‑Smad1/5/8 expression, and increased levels of gremlin in hepatocellular carcinomaOncology Letters 2018;  doi: 10.3892/ol.2018.8918
54
Roberto Ballarin, Alessandro Cucchetti, Francesco Paolo Russo, Paolo Magistri, Matteo Cescon, Umberto Cillo, Patrizia Burra, Antonio Daniele Pinna, Fabrizio Di Benedetto. Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donorsWorld Journal of Gastroenterology 2017; 23(12): 2095-2105 doi: 10.3748/wjg.v23.i12.2095
55
Can Kamali, Kaan Kamali, Philipp Brunnbauer, Katrin Splith, Johann Pratschke, Moritz Schmelzle, Felix Krenzien. Extended liver resection in mice: state of the art and pitfalls—a systematic reviewEuropean Journal of Medical Research 2021; 26(1) doi: 10.1186/s40001-020-00478-3
56
Daniel R. Rice, J. Madison Hyer, Adrian Diaz, Timothy M. Pawlik. End-of-Life Hospice Use and Medicare Expenditures Among Patients Dying of Hepatocellular CarcinomaAnnals of Surgical Oncology 2021; 28(9): 5414 doi: 10.1245/s10434-021-09606-7
57
Xu Zhao, Jian Hao, Sinuan Chen. Network Pharmacology-Based Strategy for Predicting Therapy Targets of Traditional Chinese Medicine Xihuang Pill on Liver CancerEvidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/6076572
58
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, NAOKI ISHIGE. Suppression of hepatocellular carcinoma cell proliferation by short hairpin RNA of frizzled 2 with Sonazoid-enhanced irradiationInternational Journal of Oncology 2016; 48(1): 123 doi: 10.3892/ijo.2015.3259
59
Lili Zhong, Chenhui Hou, Liang Zhang, Jianchun Zhao, Feng Li, Wenbao Li. Synthesis of deuterium-enriched sorafenib derivatives and evaluation of their biological activitiesMolecular Diversity 2019; 23(2): 341 doi: 10.1007/s11030-018-9875-7
60
Peng-Yuan Zhuang, Ke-Wei Zhang, Jian-Dong Wang, Xue-Ping Zhou, Ying-Bin Liu, Zhi-Wei Quan, Jun Shen. Effect of TALEN-mediated IL-6 knockout on cell proliferation, apoptosis, invasion and anti-cancer therapy in hepatocellular carcinoma (HCC-LM3) cellsOncotarget 2017; 8(44): 77915 doi: 10.18632/oncotarget.20946
61
Hong-Yuan Liang, Qi-Yong Guo, Wei Sun, Xiao-Nan Mao, Feng Wen, Ming Shan, Gang Zhao, Xi-Hai Wang, Zai-Ming Lu. Sequential Use of Transhepatic Arterial Chemoembolization and Bipolar Radiofrequency Ablation in the Clinical Therapy of Hepatocellular CarcinomaCancer Biotherapy and Radiopharmaceuticals 2015; 30(10): 427 doi: 10.1089/cbr.2015.1884
62
Masaki Kaibori, Kazuko Sakai, Morihiko Ishizaki, Hideyuki Matsushima, Marco A. De Velasco, Kosuke Matsui, Hiroya Iida, Hiroaki Kitade, A-Hon Kwon, Hiroaki Nagano, Hiroshi Wada, Seiji Haji, Tadashi Tsukamoto, Akishige Kanazawa, Yutaka Takeda, Shigekazu Takemura, Shoji Kubo, Kazuto Nishio. Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatmentOncotarget 2016; 7(31): 49091 doi: 10.18632/oncotarget.10077
63
Chengyong Liu, Chunying Wang, Ji Wang, Haibin Huang. miR-1297 promotes cell proliferation by inhibiting RB1 in liver cancerOncology Letters 2016; 12(6): 5177 doi: 10.3892/ol.2016.5326
64
J. Ni, C. Fu, R. Huang, Z. Li, S. Li, P. Cao, K. Zhong, M. Ge, Y. Gao. Metabolic syndrome cannot mask the changes of faecal microbiota compositions caused by primary hepatocellular carcinomaLetters in Applied Microbiology 2021; 73(1): 73 doi: 10.1111/lam.13477
65
Wafaa Ahmed, Dina Mofed, Abdel-Rahman Zekri, Nasr El-Sayed, Mohamed Rahouma, Salwa Sabet. Antioxidant activity and apoptotic induction as mechanisms of action of Withania somnifera (Ashwagandha) against a hepatocellular carcinoma cell lineJournal of International Medical Research 2018; 46(4): 1358 doi: 10.1177/0300060517752022
66
Roberto Mazzanti, Umberto Arena, Renato Tassi. Hepatocellular carcinoma: Where are we?World Journal of Experimental Medicine 2016; 6(1): 21-36 doi: 10.5493/wjem.v6.i1.21
67
Shunyan Weng, Liang Zhou, Qing Deng, Jiaxian Wang, Yan Yu, Jianwei Zhu, Yunsheng Yuan. Niclosamide induced cell apoptosis via upregulation of ATF3 and activation of PERK in Hepatocellular carcinoma cellsBMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0442-3
68
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, NAOKI ISHIGE. FH535 suppresses the proliferation and motility of hepatocellular carcinoma cellsInternational Journal of Oncology 2016; 48(1): 110 doi: 10.3892/ijo.2015.3220
69
Yousery Nada, Noha Rashad, Mai Eissa, Aya Ghonaim, Kyrillus Farag, Islam Saadawi, Ahmed Sheha, Mahmoud El Gewaity, Omar Abdel-Rahman. Outcomes of treatment with sorafenib in Egyptian patients with hepatocellular carcinoma: a retrospective cohort studyExpert Review of Gastroenterology & Hepatology 2018; 12(1): 99 doi: 10.1080/17474124.2018.1403898
70
Sachin Shetty, Anushree U, Rajesh Kumar, Sanjay Bharati. Electrical conductivity spectra of hepatic tumors reflect hepatocellular carcinoma progression in miceBiomedical Physics & Engineering Express 2020; 6(6): 065019 doi: 10.1088/2057-1976/abbbd5